Celcuity Inc. (CELC) analyst actions
Rating and price-target actions on CELC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CELC overview →
1 measured CELC analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Celcuity Inc. (CELC) And Encourages Shareholders to Reach Out | Press release | -0.55% | -0.78% |
Keep exploring
More CELC: earnings → · SEC filings → · CELC overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aurora Cannabis Inc. - Common Shares (ACB) | 354 | -0.18% | 47% |
| Avid Bioservices, Inc. (CDMO) | 354 | 0.00% | 49% |
| AnaptysBio, Inc. (ANAB) | 344 | -0.51% | 44% |
| REGENERX BIOPHARMS INC (RGRX) | 343 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.